AIDrug Development: FDA Releases Draft Guidance | Foley & Lardner LLP
In particular, the guidance outlines ariskframework based on a “context of use” of Artificial Intelligence(AI) technology and details the …
Read the original at Foley & Lardner LLP ↗
- Topics
- HealthcareGovernance & Risk Management
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”